On October 8, 2020, Australia’s Morrison government gave COVID-19 vaccine manufactures indemnity against liability for “rare” side effects that experts say are “inevitable” when a vaccine is rolled out, and a statutory compensation scheme for “extremely rare” side effects will NOT be set up. [1, 2, 3] Initially granting this to Oxford University and University of Queensland vaccines.
- The Queensland university/Seqirus (CSL) vaccine we pulled in December 2020 as recipients tested positive for HIV! The Oxford/AstraZeneca vaccine made it to market.
- In June 2021 the Australian government indemnified GP’s who administered the COVID-19 jabs, and stated it also covered recipients!
- Compensation ended September 30, 2024
This action was prompted by the World Health Organisation through Gavi’s COVAX Facility wo informed “each country receiving COVID-19 Vaccines through the COVAX Facility,” that “whether distributed under an emergency use authorization or recently licensed [they] will be required to indemnify manufacturers, donors, distributors, and other stakeholders (the “Indemnified Entities”) against any losses they incur from the deployment and use of those Vaccines…”
The WHO published a “global landscape analysis of no-fault compensation programmes for vaccine injuries” in May 2020 (preprint July 2019). “Data from this report provide an empirical basis on which global guidance for implementing such schemes could be developed”!